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a  b  s  t  r  a  c  t
Escherichia  coli  O157:H7  colonizes  cattle  intestines  by  using  the  locus  of  enterocyte  effacement  (LEE)-
encoded  proteins.  The  induction  of  systemic  immune  response  against  LEE-encoded  proteins,  therefore,
will  prove  effective  in  reducing  E.  coli O157:H7  colonization  in  cattle.  The  previous  studies  have  demon-
strated  that  a  hha  (encodes  for  a hemolysin  expression  modulating  protein)  deletion  enhances  expression
of LEE-encoded  proteins  and  a sepB  (encodes  an  ATPase  required  for the  secretion  of  LEE-encoded  proteins)
deletion  results  in intracellular  accumulation  of  LEE  proteins.  In  this  study,  we  demonstrate  the  efficacy
of the  hha  and  hha  sepB  deletion  mutants  as bacterins  for  reducing  fecal  shedding  of  E.  coli  O157:H7  in
experimentally  inoculated  weaned  calves.  The  weaned  calves  were  injected  intramuscularly  with  the
bacterins  containing  109 heat-killed  cells  of the  hha+ wild-type  or  hha  or hha  sepB  isogenic  mutants,  and
boosted  with  the  same  doses  2-  and  4-weeks  later.  The  evaluation  of  the  immune  response  two  weeks
after  the  last  booster  immunization  revealed  that  the  calves  vaccinated  with  the  hha  mutant  bacterin
had higher  antibody  titers  against  LEE  proteins  compared  to  the  titers  for  these  antibodies  in the calves
vaccinated  with  the hha  sepB  mutant  or hha+ wild-type  bacterins.  Following  oral  inoculations  with  1010
CFU  of  the  wild-type  E.  coli  O157:H7,  the  greater  numbers  of  calves  in  the  group  vaccinated  with  the  hha
or  hha  sepB  mutant  bacterins  stopped  shedding  the  inoculum  strain  within  a few  days  after  the  inocula-
tions  compared  to  the  group  of  calves  vaccinated  with  the  hha+ wild-type  bacterin  or PBS  sham  vaccine.
Thus,  the  use  of  bacterins  prepared  from  the hha  and hha  sepB  mutants  for  reducing  colonization  of  E.  coli
O157:H7  in  cattle  could  represent  a potentially  important  pre-harvest  strategy  to  enhance  post-harvest
safety  of  bovine  food  products,  water  and  produce.
Published by Elsevier Ltd.
1. Introduction
Escherichia coli O157:H7 are Shiga toxin-producing zoonotic
pathogens capable of causing gastroenteritis of varied severity in
humans of all age groups [1].  Adult cattle are asymptomatic carri-
ers of E. coli O157:H7 and these animals serve as major sources for
this pathogen [2].  The major sites for E. coli O157:H7 colonization of
bovine intestines include terminal rectum and cecum [3–5]. Cattle
colonized with E. coli O157:H7 excrete these bacteria in their feces
for variable durations and magnitudes, which in turn increases the
risk of hide contamination and contamination of carcasses during
 Disclaimer: Mention of trade names or commercial products in this article is
solely for the purpose of providing specific information and does not imply recom-
mendation or endorsement by the U.S. Department of Agriculture.
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meat processing operations [6].  The intimate adherence of E. coli
O157:H7 bacteria to epithelial cells results in the production of
characteristic attaching and effacing (A/E) lesions [3,7,8].
A 43-kb pathogenicity island termed the locus of enterocyte
effacement (LEE) encodes factors essential for the formation of A/E
lesions on intestinal epithelial cells [9–11]. LEE, which contains five
major operons (LEE1 to LEE5), encodes for a type III secretion system
(T3SS), translocated intimin receptor (Tir), intimin, and secreted
proteins EspA, EspB, EspD [12,13]. The protein EspA, an integral
component of T3SS, forms tubular structures at the bacterial cell
surface for delivering Esp proteins and Tir into intestinal epithelial
cells [14]. Tir is inserted into the epithelial cell membrane where it
interacts with intimin (an auto-transporter) located on the bacte-
rial cell surface to facilitate intimate adherence between bacterial
and epithelial cells [15,16]. The proteins secreted by T3SS cause
cytoskeletal changes in epithelial cells resulting in the production of
A/E lesions [17]. Several genetic factors regulate LEE expression by
directly or indirectly affecting the expression of Ler, LEE1-encoded
positive regulator of LEE [18]. In recent reports, we demonstrated
that a deletion of hha resulted in an increased transcription of LEE
0264-410X/$ – see front matter. Published by Elsevier Ltd.
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[19] and allowed increased adherence of the mutant E. coli O157:H7
strain to HEp-2 cells [20]
Numerous studies have demonstrated the requirement for LEE-
encoded proteins in adherence and colonization by E. coli O157:H7
of epithelial cells using in vitro adherence assays and animal mod-
els. For example, the sepB deletion mutants of E. coli O157:H7 are
unable to secrete the LEE-encoded adherence factors and are thus
compromised in their ability to adhere to epithelial cells and to
colonize animal intestines [11,12,21].  SepB, which is encoded by
the LEE3 operon, functions as an ATPase to generate energy for
the T3SS to secrete LEE proteins [12]. In another study, calves
inoculated with a library of signature-tagged mutants of E. coli
O157:H7 showed that 13 of 59 mutants impaired in their abil-
ity to colonize bovine gastrointestinal tracts had these mutations
clustered in the genes encoded by LEE [21]. Similarly, the inoc-
ulation of calves, rabbits, or pigs with E. coli O157:H7 mutants
disrupted or deleted in genes eae,  espA, espB, or tir or various com-
binations of these genes abolished or reduced the ability of these
mutants to colonize intestines of these animals [7,17,22–28]. The
importance of LEE-encoded factors in intestinal colonization was
also demonstrated in animals that could no longer be colonized or
were colonized at reduced levels by E. coli O157:H7 because of the
presence of circulating or mucosal antibodies (produced either by
vaccination or maternally acquired) to one or more LEE-encoded
proteins [29–32].
Epidemiological surveys conducted over the past several years
indicate that E. coli O157:H7 is ubiquitous at the herd level in both
dairy and beef cattle operations but prevalence of these bacteria
in individual animals or animals in pens varies greatly [33–36].
Thus, application of strategies for reducing pre-harvest prevalence
of E. coli O157:H7 at the farm is important for enhancing safety
of bovine food products and mitigating economic impact of E. coli
O157:H7 caused disease outbreaks on the public health system and
the food industry [37].
Since LEE-encoded proteins are critical in gastrointestinal colo-
nization of cattle by E. coli O157:H7, several studies have reported
evaluations of vaccines containing one or more LEE-encoded pro-
teins to reduce intestinal colonization in cattle experimentally or
naturally infected with E. coli O157:H7 [31,38–41].  However, only
one such LEE-based vaccine, called EconicheTM, has been granted
a full license for use in cattle feedlots in Canada (Bioniche Life Sci-
ences, Inc., Belleville, Ontario, Canada). The EconicheTM vaccine is a
protein cocktail prepared by concentrating T3SS-secreted proteins
from culture supernatants of E. coli O157:H7. Three dose regimens
(50 g of secreted proteins per dose) of this vaccine had been tested
for its effectiveness in reducing E. coli O157:H7 shedding in cat-
tle housed under experimental conditions and in feedlots. Cattle
housed under experimental conditions showed enhanced immune
response to several constituent secreted proteins of the cocktail
that correlated with a significant reduction in the duration and
magnitude of fecal shedding of E. coli O157:H7 [40]. Similarly, a sig-
nificant reduction in the prevalence of E. coli O157:H7 was  observed
in vaccinated versus unvaccinated feedlot cattle [41]. A non-LEE
based vaccine containing siderophore receptors and porins of E. coli
outer membranes had also been shown to be effective in reducing
shedding of E. coli O157:H7 in feedlot cattle [42].
In this study, we constructed hha and hha sepB deletion mutants
of a hha+ wild-type strain of E. coli O157:H7 and determined the
effects of these mutations on the secretion of LEE-encoded proteins
Tir, EspA, EspB and intimin. We  used these mutants as heat-killed
preparations, referred to as bacterins hereafter, for intramuscular
immunization of cattle and determined the impact of these vac-
cinations on fecal shedding of E. coli O157:H7 relative to that in
cattle vaccinated either with a hha+ wild-type bacterin or a PBS
sham vaccine. In addition, we determined relative titers of cir-
culating IgG antibodies in vaccinated cattle to assess the relative
importance of various LEE-encoded proteins in inducing immune
responses effective in reducing fecal shedding of E. coli O157:H7.
2. Methods
2.1. Bacterial strains, plasmids, and growth conditions
Table 1 lists the bacterial strains and plasmids used in this
study. All E. coli strains were propagated at 37 ◦C in Luria–Bertani
broth (LB) or LB containing 1.5% agar. For liquid cultures, colonies
from LB agar plates were inoculated into LB broth and incubated
at 37 ◦C, unless stated otherwise, on a shaker at 200 rpm. Dul-
becco’s Modified Eagle Medium (DMEM) or M9+  Medium (minimal
salts plus 1% casamino acids) were used for the optimal pro-
duction of LEE proteins in the liquid cultures [43]. Media were
supplemented, when required, with selective antibiotics at the fol-
lowing concentrations: ampicillin 50 g/ml; kanamycin 50 g/ml;
and streptomycin100 g/ml.
2.2. Primer design and PCR amplification
The primers used in this study are listed in Table 1. These primer
sequences were selected from the published sequence of E. coli
O157:H7 EDL933 genome [44], and were synthesized by Integrated
DNA Technologies (Coralville, IA). The PCR mixture contained 5 l
of DNA (0.1 g), 0.3 M each of forward and reverse primers,
15 mM Tris–HCl (pH 8.0), 50 mM KCl, 3.0 mM  MgCl2, 200 M of
each of the four dNTPs (Roche Diagnostic Corporation, Indianapo-
lis, IN), and 1.25 units of AmpliTaq Gold polymerase (PE Biosystems,
Foster City, CA). The PCR amplification was  performed by heating
the PCR mixture to 95 ◦C for 10 min  followed by 40 cycles of heat-
ing (94 ◦C for 30 s), annealing (55 ◦C for 30 s), extension (72 ◦C for
60 s per 1000 bp amplification), and termination (72 ◦C for 5 min).
The PCR amplified products were resolved by the standard agarose
gel electrophoresis. The DNA fragments of the predicted sizes were
extracted from the agarose gel by a QIAquick Gel Extraction Kit
according to the manufacturer’s instructions (Qiagen, Valencia, CA),
and concentrations of purified DNA fragments were determined
using a spectrophotometer (NanoDrop Technologies, Wilmington,
DE).
2.3. Construction of hha and hha sepB deletion mutants
The hha deletion mutant of E. coli O157:H7 strain 86-24 stx2
(Table 1) was constructed by using plasmid pSM122 and the allelic
replacement procedure described in a previous study [19]. We
used the same allelic replacement procedure to delete sepB in
E. coli O157:H7 strain 86-24 stx2 hha (Table 1). To delete sepB,
we  PCR amplified a DNA fragment containing 1500-bp upstream
(US-fragment) of the start codon and another fragment contain-
ing 1500-bp downstream (DS-fragment) of the stop codon of sepB
by using the primers VS545/VS546 and VS547/VS548, respectively.
The US- and DS-fragments were cloned into pCR-XL/TOP10 cloning
system to generate plasmids pSM281 and pSM282, respectively,
according to manufacturer’s instructions (Invitrogen Corporation,
Carlsbad, CA). The US-fragment of pSM281 was recovered by using
the restriction endonucleases BamHI (restriction site present in
pCR-XL multiple cloning site immediate upstream of 5′ end of
US-fragment) and SalI  (restriction site created at the 3′ end of US-
fragment by primer VS546). The BamHI and SalI  US-fragment was
then cloned at the corresponding BamHI (vector) and SalI  restric-
tion (created by the primer VS548 at the 5′ end of DS-fragment of
pSM282) sites to generate the plasmid pSM284 (Table 1). The 3-
kb fragment containing both the US- and DS-fragments in tandem
(5′ US-DS 3′) was  then isolated from pSM284 using XbaI, restric-
tion site created by the primers VS547 and VS545 at the 5′ and 3′
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Table 1
Bacterial strains, plasmidsa, and primers.
Strain or plasmid Genotype and description Source or reference
E. coli strains
E.  coli O157:H7 strain 86-24 stx2+ [56]
Strain  86-24 stx2 86-24 deleted of stx2 [19]
Strain  86-24 stx2 hha 86-24 deleted of stx2 and hha This study
Strain 86-24 stx2 hha sepB 86-24 deleted stx2, hha, and sepB This study
TOP  10 endA1 recA1 hsdR17 (rK− mK−) supE44 Invitrogen
Plasmids
pCR-XL  Cloning vector Invitrogen
pAM450 Temperature-sensitive allelic replacement vector [25]
pSM122 pAM450 derivative used for deleting hha [19]
pSM281 1.5-kb sequence located upstream of sepB (escN) cloned in pCR-XL This study
pSM282 1.5-kb sequence located downstream of sepB (escN) cloned in pCR-XL This study
pSM284 1.5-kb sequence of pSM282 cloned downstream of 1.5-kb sequence of pSM281 This study
pSM302 3-kb sequence of pSM284 containing upstream and downstream sequences of
sepB (escN) cloned in pAM450
This study
Primers used for PCR amplification
Primer Nucleotide sequence (5′–3′)b Location (bp)c
VS501 ACGTTTGGCTTATTGGCTCTG 4676296–4676276
VS545 GCGTCTAGAGCGCGCAGGCGTTATTGACCC 4677526–4677546
VS546 GCGGTCGACTTACCGTTCCTAATACTTTAAGTTCG 4676018–4676043
VS547  GCGTCTAGACGCAACATGTGTATATCAATATGGAC 4673159–4673184
VS548  GCGGTCGACGTATGTTGGACAGAATTTATCTATTC 4674675–4674650
VS561  CACCAGCGATGCACAATATGCCTG 4674507–4674530
a The detailed descriptions of bacterial strains and plasmids listed in this table is provided under Section 2.
b The nucleotide sequences of primers used in this study were selected from the published complete genome sequence of E. coli O157:H7 strain EDL933 with the accession
number AE005174.2.
c Location refers to the position of primer sequence in the genome of EDL933.
ends, respectively, and cloned into the XbaI site of a temperature-
sensitive plasmid pAM450 (Table 1) to generate a recombinant
plasmid pSM302. The plasmid pSM302 was electroporated into
E. coli O157:H7 strain 86-24 stx2 hha,  and the new strain 86-
24 stx2 hha/pSM302 was cultured under growth conditions, as
described previously [19], that facilitated deletion of the chromoso-
mal  copy of sepB. The deletion of sepB was confirmed by PCR using
the primers VS501 and VS561 (Table 1).
2.4. Precipitation and quantification of secreted proteins and
preparation of whole-cell lysates
The bacterial strains were grown in M9+  or DMEM media at
37 ◦C overnight and diluted 1:500 into fresh M9  or DMEM media
and incubated at 37 ◦C for 6 h. The cultures were adjusted to A600 nm
of 1.0 and centrifuged at 10,000 × g for 10 min. The cell pellets were
resuspended in 1 ml  of TBS (0.1 M Tris, 0.154 M NaCl, pH 7.4) and
stored at −20 ◦C until used for making the whole-cell lysates. The
culture supernatants were mixed with tricholoroacetic acid (TCA)
to a final concentration of 10%, incubated overnight at 4 ◦C, and
centrifuged for 30 min  (10,000 × g). After discarding supernatants,
the TCA pellets were resuspended in 0.1 M TBS and then stored at
−20 ◦C. The protein content of resuspended TCA precipitates was
estimated from A280 nm measurements of these samples.
2.5. SDS–PAGE and Western blotting
Two-volumes of TBS-suspended cell pellets or TCA precipitated
proteins, prepared from the cultures adjusted to A600 nm of 1.0
as described above, were mixed with one-volume of SDS sample
buffer (Invitrogen Corporation, Carlsbad, CA) and incubated at 95 ◦C
for 5 min. The boiled samples were loaded into the wells of a 10–20%
Tris–Tricine (Invitrogen Corporation, Carlsbad, CA) or 4–20% Tris-
buffered (Biorad Laboratories, Hercules, CA) SDS–polyacrylamide
gels. The gels were subjected to electrophoresis using a SDS–PAGE
running buffer (Invitrogen Corporation, Carlsbad, CA) at a con-
stant voltage to resolve proteins present in the whole-cell lysates
or TCA-precipitates of culture supernatants. The gels were either
stained with Coomassie brilliant blue to visualize the presence of
total proteins or used for transferring the proteins to nitrocellu-
lose membranes (Schleicher and Schuell, Inc., Keene, NH) using a
standard western blotting procedure.
2.6. Detection of T3SS secreted LEE proteins
The nitrocellulose membranes, following the western blotting of
proteins, were secured and processed in a multichannel miniblotter
according to the manufacturer’s instructions (Immunetics, Boston,
MA). The unbound sites on the membranes were blocked by
adding 50 l of TBS-T (TBS containing 0.05% Tween 20) [29] to
each well for 5 min. The blocking step was  repeated for a total
of 3 × 5 min. For detecting the presence of LEE-encoded proteins
in whole-cell lysates or TCA-precipitated culture supernatants of
the hha+ wild-type and hha and hha sepB mutant strains, 50 l of
rabbit antibodies (diluted 1:5000 in TBS-T) prepared against puri-
fied EspA, EspB (kindly provided by Dr. Jorge Giron, University of
Florida, Gainesville, FL), Tir and intimin (kindly provided by Dr. Ali-
son O’Brien, Uniformed Services University of the Health Sciences,
Bethesda, MD)  were added to individual tracks for detecting EspA,
EspB, Tir, and intimin. After 60 min  of incubation at the room tem-
perature, the unbound antibodies were washed off by adding 50 l
of TBS-T to each track and letting it incubate for 5 min. The washing
was  repeated for two additional times. Fifty l of biotinylated goat
anti-rabbit IgG (Vector Laboratories, Inc., Burlingame, CA) diluted
in 0.4% Block Ace in TBS-T (Serotec, Oxford, UK) was  added to each
well. Following incubation at the room temperature for 30 min,
the membranes were washed with TBS-T (3 × 5 min), and removed
from the blotter. The membranes were developed using Vector ABC
staining kit according to the manufacturer’s instructions (Vector
Laboratories, Inc., Burlingame, CA).
2.7. Detection of antibodies against LEE-encoded proteins in sera
of vaccinated animals
The western-blotted nitrocellulose membranes containing
transferred TCA-precipitated proteins (described above) were used
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for determining anti-intimin, anti-Tir, anti-EspA, and anti-EspB
titers in the sera prepared from the blood collected at pre- and four
weeks post-vaccination of calves with bacterins. These blots were
processed as described above with the exception that the diluted
pre- and post-immune sera (100 l of 1:100, 1:500, and 1:1000
dilution in TBS-T) were used as a source of primary antibodies and
the biotinylated goat anti-bovine IgG was used as a secondary anti-
body. After washing (3 × 5 min), the membranes were developed
using Vector ABC staining kit (Vector Laboratories, Inc., Burlingame,
CA), and the intensities of the colored bands produced on the mem-
branes were determined on ChemiDoc Imager (BioRad) using a
QuanityOne software.
2.8. Preparation of bacterins
The hha+ wild-type and hha and hha sepB mutant strains of E. coli
O157:H7) were propagated overnight in LB broth containing 100 g
per ml  of streptomycin in a shaker-incubator (37 ◦C, 200 rpm). The
overnight culture of each strain was diluted 1:100 in DMEM and
incubated at 37 ◦C for 6 h (200 rpm). The cultures were centrifuged
at 5000 × g for 10 min, supernatants removed and the cell pellets
resuspended in phosphate-buffered saline (PBS) to one-tenth the
volume of the original culture. An aliquot of the PBS-bacterial cell
suspension was diluted (10-fold serial dilutions), plated on LB agar
containing streptomycin, and incubated overnight at 37 ◦C. The
number of colonies that grew on these plates provided total viable
cell counts of these bacterial suspensions. The remainder of the
PBS suspension was incubated in a heated water-bath (80 ◦C) for
30 min  to kill bacterial cells. One hundred l aliquots of heated
cell suspensions were plated on LB agar containing streptomycin
and incubated overnight at 37 ◦C to confirm that the heated cells
were not viable. Based on the viable cell counts, the remainder of
the heat-killed suspension was adjusted to about 109 cells per ml
before storing at −4 ◦C.
2.9. Vaccination of calves and detection of antibodies directed
against LEE-encoded proteins in vaccinated calves
The weaned male calves (8–10 weeks in age) were purchased
from local farms in Iowa and were housed in accordance with
the guidelines of the American Association for Laboratory Animal
Care. The calves were housed in pairs in climate-controlled BL-2
barns and were allowed to acclimate for 2-weeks to the animal
housing environment prior to experimentation. The calves were
fed twice daily with both the pelleted feed and alfalfa hay cubes
in amounts (16% crude protein, 2.5% crude fat, 8% fiber) equal to
1% of their body weights, and water was offered ad libitum. All
animal protocols were approved by the National Animal Disease
Center Animal Care and Use Committee. In each of the three vac-
cine trials conducted, eight calves were divided into four groups
of two calves each. The blood samples were taken from the jugu-
lar vein as preinoculum samples. While the calves in the group 1
were injected with 1-ml of phosphate-buffered saline (PBS), the
calves in groups 2, 3, and 4 were injected with the heat-killed vac-
cines (containing 109 cells/ml), called bacterins, prepared from the
hha+ wild-type, or hha,  or hha sepB mutant strains, respectively.
The use of bacterins at 109 cells per ml  in the current study was
based on the previously published reports describing the effec-
tiveness of an E. coli J-5 bacterin for its protective effects in calves
from mastitis and endotoxin-caused diseases [45,46]. All injections
were administered intramuscularly in the neck using an 18-Gauge
needle attached to a syringe. All animals were revaccinated at
week 2 and 4 post initial vaccination. The blood samples were col-
lected two weeks post-second vaccination and the sera prepared
from these blood samples were used for measuring the IgG titers
against intimin, Tir, EspA, and EspB by immunoblotting as described
above.
2.10. Determination of fecal shedding of E. coli O157:H7 in
vaccinated calves
Two weeks after the third booster dose of the bacterins, all calves
were administered gelatin capsules containing 1-ml (1010 CFU)
of a culture of a wild-type E. coli O157:H7 (strain 86-24) and a
few feed pellets. A balling gun was  used for delivering the cap-
sules into the calf pharynx. The feces were collected everyday for
two  weeks by the rectal palpation of calves. Ten-fold serial dilu-
tions of feces were prepared in PBS and 100 l aliquots plated on
duplicate sets of Sorbitol MacConkey agar containing 100 g/ml
of streptomycin. After incubating plates at 37 ◦C for 24 h, white,
sorbitol-negative colonies were counted for determining viable
colony forming units (CFU) of E. coli O157:H7 in feces. Several
colonies were randomly picked and tested for agglutination with
an E. coli O157:H7-specific antiserum (Oxoid, Unipath Ltd., Ogdens-
burg, NY). The sensitivity of detection was 102 bacterial CFU/g of
feces.
2.11. Statistics
The significance of the differences in the outcome variables,
such as the numbers of animals shedding or the duration of shed-
ding of E. coli O157:H7 in feces among animals vaccinated with
different bacterins, was  determined using an Unpaired Student t-
test with a two-tailed P value estimation or the one-way ANOVA
(Kruskal–Wallis test with Dunn’s Multiple Comparison). The differ-
ences in the outcome variables were considered significant if the P
values were less than 0.05.
3. Results
3.1. T3SS-mediated secretion of LEE-encoded proteins is
enhanced in hha and reduced in sepB deletion mutants
Since previous studies have shown that a hha deletion results
in an increased LEE transcription [19] and a sepB deletion abro-
gates T3SS activity [43], we  wanted to determine relative activities
of T3SS in the hha and hha sepB mutants by monitoring the levels
of LEE-encoded proteins secreted into the bacterial culture super-
natants. The total protein content of a TCA-precipitated culture
supernatant of the hha mutant was  about 2-fold higher (3.3 mg/ml)
than that of the hha+ wild-type (1.6 mg/ml) and 1.5-fold higher
than the hha sepB mutant (2.1 mg/ml). As shown in the Coomassie
blue stained SDS–polyacrylamide gel (Fig. 1A), TCA-precipitates
of the hha mutant culture supernatant contained several proteins
that were readily visible (lane 2) compared to only a few barely
detectable but identical protein bands in the TCA-precipitated
culture supernatants of the hha+ wild-type (lane 1) or the hha
sepB mutant (lane 3) strains, respectively. Four of these protein
bands appeared to approximate the masses predicted for EspA
(21 kDa), EspB (34 kDa), Tir (62 kDa), and intimin (102 kDa) of E. coli
O157:H7. The protein profiles of the whole-cell lysates prepared
from the hha+ wild-type (lane 1), hha mutant (lane 2), and hha sepB
mutant (lane 3) strains were similar (Fig. 1B). The probing of the
nitrocellulose membranes carrying immobilized TCA-precipitated
proteins with the antibodies specific for LEE-encoded EspA, EspB,
Tir, and intimin, showed intense bands (Fig. 2) corresponding to
these proteins in the hha mutant (middle panel), two  of the four
bands (EspA and EspB) in the hha+ wild-type (left panel), and
none of the four proteins in the hha sepB mutant strains (right
panel).
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Fig. 1. Determination of the effects of hha and sepB deletions on T3SS-mediated protein secretion. Trichloroacetic acid precipitated culture supernatants (A) and whole-cell
lysates (B) were resolved by SDS–PAGE and gels were stained with Coomassie brilliant blue to visualize protein bands. The numbers and relative abundances of protein
bands  are shown in lane 1 (hha+ wild-type strain), lane 2 (hha deletion mutant), and lane 3 (hha sepB deletion mutant). Lanes labeled MW,  represent protein molecular mass
standards in kilodaltons (kDa), indicated on left. The approximate molecular masses of secreted proteins are indicated on the right side of (A).
3.2. sepB deletion enhances intracellular accumulation of
LEE-encoded proteins
Since sepB deletion has been shown to compromise T3SS-
mediated secretion of several LEE-encoded proteins [12], we  next
examined whether a sepB deletion would result in an increased
intracellular accumulation of LEE-encoded proteins. As shown in
Fig. 3, the western blot analysis of the whole-cell lysates showed
the presence of bands corresponding to intimin, Tir, EspB and EspA
in the hha+ wild-type, and hha and hha sepB mutant strains (Fig. 3).
However, a visual examination of this gel showed higher amounts
of these four proteins in the hha and hha sepB mutants than in
the hha+ wild-type strain. Several low-molecular weight proteins,
which could either represent truncated or degraded species, were
also detected in the lanes corresponding to intimin, Tir, and EspB
in blots prepared from the wild-type and the two  mutant strains.
Fig. 2. Identification and determination of relative abundance of LEE-encoded pro-
teins by Western blotting. Trichloroacetic acid precipitated culture supernatants
prepared from hha+ wild-type (left panel), hha mutant, (middle panel), and hha sepB
mutant (right panel) strains were probed with rabbit anti-intimin (lane 1), anti-
Tir (lane 2), anti-EspA (lane 3) and anti-EspB (lane 4). Lane labeled MW represents
molecular mass standards in kilodaltons (kDa).
3.3. Vaccination enhanced immune response to LEE-encoded
proteins
The animal sera prepared from the blood collected pre- or
4-weaks post-vaccination were analyzed by western blotting to
determine the IgG titers for specific LEE-encoded proteins. As
shown in Table 2, the group of calves administered the PBS sham
vaccine showed no change in the median titers for IgG against
intimin, Tir, EspA, and EspB between the pre- and post-vaccination
sera. On the other hand, the post-vaccination sera of the calves vac-
cinated with the hha+ wild-type or the hha or the hha sepB mutant
bacterins had increased median titers for these four IgG antibod-
ies with the exception that the IgG titers against EspA remained
the same in the pre- and post-vaccination sera of the calves vac-
cinated with the hha+ wild-type bacterin. The highest titers for
the four antibodies were detected in the post-vaccination sera
of the calves vaccinated with the hha mutant bacterin. The post-
vaccination median titers for the anti-intimin IgG in the group of
calves vaccinated with the hha sepB bacterin were 2-fold or 3-fold
lower than the calves vaccinated with the hha+ wild-type or the hha
Fig. 3. Identification and determination of relative abundance of LEE-encoded pro-
teins in whole-cell lysates by Western blotting. The whole- cell lysates prepared
from hha+ wild-type (left panel), hha mutant (middle panel), and hha sepB mutant
(right panel) strains were probed with rabbit anti-intimin (lane 1), anti-Tir (lane 2),
anti-EspA (lane 3) and anti-EspB (lane 4). Lane labeled MW,  represent molecular
mass standards in kilodaltons (kDa).
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Table  2
Serum titers produced against LEE-encoded proteins in calves after vaccination.
Bacterins used Median serum titersa
Anti-intimin Anti-Tir Anti-EspB Anti-EspA
Prevac.b Postvac.b Prevac. Postvac. Prevac. Postvac. Prevac. Postvac.
hha+ wild-type 10 255 55 500 100 500 10 10
hha  mutant 100 300 300 1000 100 1000 10 300
hha  sepB mutant 10 100 100 500 100 750 55 100
PBS 100 100 100 100 100 100 55 55
a The median titers represent the reciprocals of the highest dilutions of serum yielding colored precipitates on blotted membranes.
b Pre-vaccination and 4-weeks post-vaccination.
mutant bacterins, respectively. The group of calves vaccinated with
the hha sepB mutant bacterin also showed 1.5-fold lower anti-EspB
IgG median titers than in the calves vaccinated with the hha+ wild-
type bacterin. The most notable observation was  that the anti-EspA
IgG titers were 30-fold or 10-fold higher in the calves vaccinated
with the hha or the hha sepB mutant bacterins, respectively, com-
pared to titers for this antibody in the calves vaccinated with the
hha+ wild-type bacterin.
3.4. Vaccination reduced the duration of shedding and the
numbers of animals shedding E. coli O157:H7
The effects of vaccinations on the ability of E. coli O157:H7 to
colonize and persist in the vaccinated calves were determined by
comparing the mean number of calves that were positive for the
presence of E. coli O157:H7 in their feces over a 2-week sampling
period, and the number of days each calf continued to shed E. coli
O157:H7 in feces. As shown in Fig. 4, significantly (P < 0.05) fewer
calves were found positive among the calves vaccinated with the
hha (mean, 2.4 calves) or the hha sepB (mean, 2 calves) mutant
bacterins compared to the calves vaccinated with the hha+ wild-
type bacterin (mean, 4.6 calves). The numbers of calves shedding
E. coli O157:H7 were lower (mean, 3.3 calves) in the group of calves
vaccinated with the PBS sham than in the group vaccinated with
the hha+ wild-type bacterin (mean, 4.6), but this difference was
not statistically significant (P > 0.05).
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Fig. 4. Determination of numbers of calves shedding E. coli O157:H7 post-
vaccination. The mean numbers of calves shedding detectable levels of E. coli
O157:H7 after vaccination with a PBS sham vaccine or bacterins prepared from
hha+ wild-type or hha or hha sepB deletion mutants were estimated by averaging
the numbers of calves shedding E. coli O157:H7 each day of the two  weeks of fecal
sampling period. The mean values for the numbers of calves shedding E. coli O15:H7
plus and minus the standard error of the means (SEM) are indicated in the corre-
sponding bar. The significance of the variance (P < 0.05) of the means is shown as a
single or double asterisk.
The evaluation of the duration of fecal shedding of E. coli
O157:H7 revealed that the calves vaccinated with either the hha
or the hha sepB mutant bacterin had 50% (3 of 6 calves in each
group) of the calves stopped shedding detectable levels of E. coli
O157:H7 within 1–2 days after oral inoculations with the wild-type
E. coli O157:H7 (Fig. 5). The mean durations of fecal shedding for
the calves vaccinated with the hha or the hha sepB mutant bacterins
were 5.7 days ± 2.1 and 4.8 days ± 1.7, respectively. This reduction
in the duration of fecal shedding in these two groups of vaccinated
calves was  statistically significant (P < 0.05) when compared to the
duration of shedding in the calves vaccinated with the hha+ wild-
type bacterin (6 of 6 calves shedding for 9–14 days, with the mean
duration of shedding lasting 10.8 days ± 0.75). Of the remaining
three calves in the group vaccinated with the hha mutant bacterin,
two  calves were positive for fecal shedding for 8 and the third
calf for 14 days of the 14-day fecal sampling period. Similarly, the
remaining three calves in the group vaccinated with the hha sepB
mutant bacterin continued shedding E. coli O157:H7 for 8–9 days. In
the PBS sham vaccinated group, four calves remained positive for
fecal shedding for 9–11 days (mean duration of shedding at 7.67
days ± 1.5) and the other two  calves had detectable levels of E. coli
O157H7 in their feces for 3 days. Thus, difference in the duration of
fecal shedding in the PBS sham group was  not statistically signif-
icant (P ≥ 0.5) when compared to the duration of shedding in the
group of calves vaccinated with the hha+ wild-type bacterin.
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Fig. 5. Determination of the duration of fecal shedding of E. coli O157:H7 in vacci-
nated animals. The mean duration of fecal shedding in calves administered a PBS
sham vaccine or bacterins prepared from hha+ wild-type or hha or hha sepB dele-
tion  mutants was estimated by averaging the total number of days in a 2-week
fecal sampling period (following oral inoculation with a live E. coli O157:H7) that
the calves were determined positive for the presence of detectable levels (102 cfu/g
feces) of the inoculum strain. The mean duration of shedding for each group of calves
is  shown as a horizontal bar intersected by a vertical bar representing the standard
error of the means (SEM). The significance of the variance (P < 0.05) of the means is
shown as a single or double asterisk above the SEM line.
5084 V.K. Sharma et al. / Vaccine 29 (2011) 5078– 5086
4. Discussion
In this study, we described for the first time the potential appli-
cation of bacterins for reducing the fecal shedding of E. coli O157:H7
in cattle. The premise for the development of the bacterins was to
expose the immune system of cattle to multiple LEE-encoded pro-
teins that are critical to the ability of E. coli O157:H7 to colonize
cattle intestines, which in turn promote the long-term fecal shed-
ding of these bacteria. The importance of LEE-encoded proteins as
potential vaccine candidates has been evident in earlier studies that
have used component vaccines containing either one or two LEE-
encoded proteins or a combination of a LEE- and a non-LEE encoded
proteins to immunize non-bovine animal species. For example, it
has been demonstrated that the transfer of maternal anti-intimin
antibodies to suckling piglets of sows immunized with a purified
intimin, protected these piglets from E. coli O157:H7-caused dis-
ease compared to piglets that suckled on non-vaccinated sows [29].
Similarly, an oral feeding of a plant cell-based intimin vaccine to
mice reduced the duration of shedding of E. coli O157:H7 in the
feces of vaccinated animals [30]. Since these earlier studies, the
component vaccines containing one or two LEE-encoded proteins or
a combination of one LEE- and one non-LEE-encoded protein have
been tested in experimental vaccinations of cattle for successfully
inducing humoral immune responses to vaccine-specific proteins,
but none of these studies showed a reduction in the fecal shed-
ding of E. coli O157:H7 in vaccinated animals [47,48].  On the other
hand, the vaccine preparations containing multiple LEE-encoded
proteins have been found effective in inducing humoral immune
responses to the LEE-encoded antigens contained in these vaccines,
and in reducing the shedding of E. coli O157:H7 in the immunized
cattle [31]. However, the preparation of these vaccines requires
either the purification of individual LEE-encoded proteins using
expression vector systems or a recovery of these proteins by an acid
precipitation of culture supernatants of E. coli O157:H7. To circum-
vent the problem of purifying or precipitating proteins for use in
the vaccine preparations, we used the hha deletion mutant as the
basis for developing the bacterins because this mutant has been
shown to express LEE at very high levels [19]. As demonstrated
in the current study, the levels of several LEE-encoded proteins,
especially EspA, EspB, intimin, and Tir, were higher in the cell-free
supernatants and the whole-cell lysates of the hha deletion mutant
indicating that these proteins represented major immunogens in
the bacterins prepared from this mutant strain. This hypothesis is
supported by the results showing that a parenteral administration
of the hha-mutant based bacterins to cattle resulted in the highest
increases of humoral immune responses to LEE-encoded proteins
EspA, EspB, and Tir compared to the immune responses generated
against these proteins in cattle administered the hha+ wild-type
bacterin or the PBS sham vaccine. Whether these humoral anti-
bodies are transported to the intestinal mucosa to inhibit E. coli
O157:H7 colonization or if the parenteral vaccination is also capa-
ble of inducing a mucosal immune response to the antigens present
in the vaccine preparations, however, remains to be determined.
The increased immune response to LEE-encoded proteins in
the calves vaccinated with the hha or hha sepB mutant bacterins
reduced the numbers of animals shedding E. coli O157: H7 and the
duration of fecal shedding of these bacteria in feces compared to the
calves vaccinated with the hha+ wild-type bacterin or with the PBS
sham vaccine. One of the most striking findings of the vaccination
was that an increase in the anti-EspA IgG titers was seen only in the
calves vaccinated with the hha or hha sepB mutant bacterins, indi-
cating that an increased immune response to EspA is critical for
reducing the fecal shedding of E. coli O157:H7. Interestingly, the
calves vaccinated with the hha sepB mutant bacterin showed 2 to
3-fold lower IgG titers against intimin, Tir, EspA, and EspB IgG com-
pared to the calves vaccinated with the hha mutant bacterin. Since
intimin, Tir, EspA, and EspB are considered important in inducing a
humoral immune response in vaccinated animals [31,40,47–50], a
compromised translocation of these proteins to the bacterial outer
membranes of the hha sepB mutant may  account for reduced IgG
titers observed against these proteins in the sera of animals vac-
cinated with the hha sepB bacterin. The reduced translocation of
these proteins is presumably responsible for a lowered magnitude
of the immune response observed for these proteins in the calves
vaccinated with the hha sepB bacterin. However, the hha sepB bac-
terin appears to be as effective as the hha mutant bacterin in terms
of its ability to reduce the overall duration of fecal shedding and to
reduce the numbers of animals shedding E. coli O157:H7. Although
the genetic and molecular nature of the factors contributing to
the effectiveness of the hha sepB bacterin are hitherto unknown,
it is possible that the hha sepB double deletion causes quantitative
and/or qualitative changes in some unknown bacterial cell surface
proteins that could potentially induce an immune response com-
parable in effectiveness to the hha mutant bacterin. For example,
a recent study had demonstrated that a parenteral administration
of a bacterial cell surface siderophore receptor protein-based (SRP)
vaccine induced humoral immune response in cattle to SRP, and
induction of anti-SRP antibodies was effective in reducing the fecal
shedding of E. coli O157:H7 in vaccinated versus un-vaccinated
cattle [42,51,52].
Although an enhanced expression of the LEE-encoded proteins
appears to be directly responsible for the induction of a systemic
immune response to the LEE proteins in calves vaccinated with
the bacterins prepared from the hha mutant, deleting hha and
stx2 in E. coli O157:H7 strain used for preparing these bacterins
might also indirectly potentiate immunogenicity of these bacterins.
For example, a previous study demonstrated that a hha deletion
reduces the expression of fliC,  the gene encoding flagellin, a major
structural subunit of the flagella in E. coli O157:H7 [53]. Since the
presence of flagellin in vaccine preparations has been suggested
to impair the efficacy of these vaccines against E. coli O157:H7
due to the neutralization of TLR5 activation and an impairment
of host innate immune response [54], the reduced expression of
flagellin caused by the hha deletion would presumably facilitate
an increased immune response in the animals vaccinated with the
bacterins derived from the hha deletion mutants of E. coli O157:H7.
These observations might explain why  the greater numbers of ani-
mals in the group of calves vaccinated with the hha+ wild-type
bacterin were positive for fecal shedding compared to the PBS sham
vaccinated group of calves. Similarly, deleting stx2 in the bacterin
strains that we have used in this study is advantageous as it has
been demonstrated that the presence of stx2 reduces lymphoprolif-
erative immune response in cattle inoculated with the stx2-positive
E. coli O157:H7 compared to cattle inoculated with the stx2 deletion
mutants [55].
Other potential advantages of the bacterins that we have
described in this study are the ease and the low-cost of preparation
compared to the vaccines that require purification and concentra-
tion of LEE-encoded or other proteins. In addition, novel bacterins
could easily be constructed from specific mutants of E. coli O157:H7
for delivering large quantities of not only the LEE-encoded proteins
but also other bacterial antigens to induce systemic and/or localized
immune responses to multiple colonization factors for reducing
E. coli O157 colonization of cattle intestines.
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